Jan 8 (Reuters) - Forest Laboratories Inc said it would buy privately held specialty pharmaceutical company Aptalis for about $2.9 billion to gain access to Aptalis's gastrointestinal and lung drugs.
The deal, which will require clearance from U.S. and Canadian antitrust authorities, is expected to add about 78 cents per share to Forest's 2015 adjusted earnings.
Futures fell on reports of Iran explosions: The market power trend is about to end. Netflix gave weak guidance.
The S&P 500 could bottom out in the next month, according to Fundstrat's head of research Tom Lee.
(Bloomberg) -- European and US equity index futures declined as global markets were rocked by fresh conflict in the Middle East that sent stocks lower while oil and haven assets including Treasuries and the dollar higher. Most Read from BloombergElon Wants His Money BackDubai Grinds to Standstill as Flooding Hits CityIsrael Launches Retaliatory Strike on Iran, US Officials SayRecord Rainfall in Dubai? Blame Climate Change, Not Cloud SeedingThese Are the World’s Best Airports in 2024Gains for Tre
Trump Media is advising investors on ways to prevent their shares from being loaned for a short-interest position.
Wall Street's most-prominent stock-split stock of 2024 has been purchased on three separate occasions by a lawmaker who completed over 4,200 trades last year.
Her flagship Ark Innovation ETF has lost 18% this year.
The insurer was accused by a short-seller of "extensive" fraud.
In the chaos of the 2008 recession, perhaps no bank stood more prepared than Jamie Dimon's J.P Morgan Chase & Co. (NYSE:JPM). In advance of the crisis, Jamie Dimon realized that "underwriting standards were deteriorating across the industry," with late payments on subprime loans rising. In late 2006, the bank led his firm to exit Wall Street's hot subprime business, starting with a frantic call made to J.P. Morgan's vacationing Chief of Securitized Products where he said, "I really want you to w
These members of Congress delivered greater returns than Warren Buffett in 2023.
Pfizer stock remains under pressure despite becoming one of the biggest names of the pandemic. Is PFE stock a sell?